Markets

Company News For Jan 4, 2019

  • Shares of Bristol-Myers Squibb Company BMY declined 13.3% after it announced that it will acquire Celgene Corporation CELG for $74 billion in cash and stock
  • Shares of Delta Air Lines, Inc. DAL declined 8.9% after the company stated that it expected its December revenue to grow 3%, lower than the previous projection of 3.5%
  • Tribune Media Company's TRCO shares slumped 0.1% after the company pulled its TV stations from Spectrum, the Charter Communications owned cable operator after the two parties could not reach a carriage agreement
  • Atara Biotherapeutics, Inc.'s ATRA shares slumped 19.5% after the company's CEO Isaac Ciechanover announced plans to step down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Delta Air Lines, Inc. (DAL): Free Stock Analysis Report

Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report

Tribune Media Company (TRCO): Free Stock Analysis Report

Atara Biotherapeutics, Inc. (ATRA): Free Stock Analysis Report

Celgene Corporation (CELG): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ATRA BMY DAL

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More